Lynne Marie Sullivan - CFO & Head of Corp. Dev. at Unity Biotechnology, Inc.

Issuer-level insider activity

Role
CFO & Head of Corp. Dev.
Issuer ticker
UBX
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Lynne Marie Sullivan since 21 Aug 2025

Reported holdings for Lynne Marie Sullivan in Unity Biotechnology, Inc.

Form 4 holding CFO & Head of Corp. Dev.

Unity Biotechnology, Inc.

Security class
Common Stock, $0.0001 par value
Shares / value
98,905
Estimated value
$101,872
Report date
02 Apr 2025
Price
$1.03
Ownership
Direct
Form 4 holding CFO & Head of Corp. Dev.

Unity Biotechnology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
106,000
Estimated value
Report date
28 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Lynne Marie Sullivan in Unity Biotechnology, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .